The Clorox Company reported significant top-line expansion in its first quarter of fiscal year 2027, with net sales reaching $1.91 billion. Results were heavily influenced by the integration of the GOJO acquisition and the lapping of significant inventory drawdowns related to an ERP transition in the prior year.
Key Highlights
- Organic volume growth of 17% significantly exceeded the 2.4% expectation, primarily driven by the recovery of shipments following the previous year's system disruptions.
- Net sales increased 33% year-over-year, including a 15-percentage point contribution from the GOJO acquisition and 18 points from organic growth.
- Gross margin compressed 130 basis points to 40.4%, missing the 42% target as commodity inflation and manufacturing costs offset productivity gains.
- Adjusted EPS of $1.55 beat the $0.97 estimate, benefiting from the high volume and a lower effective tax rate.